top of page
Embryonic Stem Cells

TRCCC News

UVA.png

TRCCC Welcomes UVA!

At the close of the 2024 annual meeting of TRCCC, the University of Virginia Comprehensive Cancer Center became a TRCCC member institution.  UVA CCC will be represented on the TRCCC Board of Directors by two individuals to be named in the coming weeks.

 

Welcome to the TRCCC family UVA CCC! 

Lotze_2021.jpg
Pitt_Hillman.jpg

Dr. Lotze Named JITC Editor-in-Chief!

TRCCC would like to congratulate Dr. Mike Lotze (UMPC-Hillman Cancer Center) on his appointment as the Journal for ImmunoTherapy of Cancer (JITC) Editor-in-Chief.

JITC is the official journal of the Society for Immunotherapy of Cancer (SITC).

Dr. Lotze is a founding member and former president of TRCCC as well as a fixture at each annual meeting.  

Congratulations Mike!

Vonderheide_Robert.jpg
Penn Medicine.png

NAM Elects Dr. Vonderheide

TRCCC would like to congratulate Dr. Robert Vonderheide (University of Pennsylvania) on his well-deserved election to the National Academy of Medicine (NAM).

Election to the NAM is one of the nation’s highest honors in the fields of health and medicine and we are delighted to acknowledge and celebrate Dr. Vonderheide's remarkable achievement. 

Read more here: National Academy of Medicine elects five new members from Penn  | Penn Today

Owonikoko_Taofeek.jpg
Pitt_Hillman.jpg

Dr. Owonikoko Named Director of UMGCCC

Taofeek K. Owonikoko, MD, PhD (UMPC-Hillman Cancer Center), has been appointed Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). 

Read more here: Internationally-Recognized Thoracic Oncologist Dr. Taofeek K. Owonikoko Named Executive Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Join our Mailing List!

bottom of page